In this episode we hear a presentation given by Dr. Richard Kraig, the chief scientific officer and the inventor behind Seurat Therapeutics. Dr. Kraig explains the science and data behind Seurat’s Insulin-like Growth Factor 1 Nasal Spray, a novel migraine prevention treatment that is currently in development. *The contents of this podcast is intended for general informational purposes only and do not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condit ..read more

In this episode, we talk to the Henry family who has honored the memory of their loved one lost to migraine disease with the creation of the Danielle Byron Henry Migraine Foundation. The Henrys are committed to instilling hope in people with migraine through their educational and awareness-building programs, including their support of the Headache School and the Shine Her Light events. This podcast is sponsored in part by Amgen/Novartis and Alder BioPharmaceuticals. *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal a ..read more

In this episode, Dr. Christopher Gottschalk gives a presentation explaining research currently being done at Yale University on the use of psychedelic mushrooms in the treatment of migraine and cluster headache. Additionally, he explains the derivatives and characteristics of drugs currently being used for migraine and cluster treatment and how they compare to psychedelics. This podcast is sponsored in part by Amgen/Novartis and Alder BioPharmaceuticals. *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the c ..read more

In this episode, we hear more about the relationship between hormones and migraine over the course of a woman’s life. Neurologist, Dr. Janet Waters discusses migraine and other causes of headaches during pregnancy including medications used and their side effects. Dr. Mary Angela O’Neal continues by discussing the differential diagnosis of secondary headaches in the postpartum period, as well as migraine treatment options during lactation. Lastly, we hear from Dr. Marcie Richardson who explains the role of hormones in migraine during perimenopause and menopause, as well as the use of hormonal ..read more

This extended episode features three lectures on the relationship between hormones and migraine. First, Dr. Julie Roth, a women’s neurologist provides an overview of the differences in migraine manifestation in men vs. women and an explanation on the cause of these differences. In section two, neurologist Dr. Amy Hessler discusses menstrual migraine. She explains the timing of migraine during the menstrual cycle and an assessment of current treatment options for menstrual migraine. Lastly, Dr. Renee Eger, an OB-GYN, summarizes contraceptive options and hormonal management for premenopausal wom ..read more

In this episode, Shoshana Lipson shares anecdotal reports about using CGRP medications for migraine compiled by surveying the 6,000+ member Facebook group CGRP and Migraine Community, which she founded. She details the findings in four areas: Efficacy & expectations, adverse side effects, accessibility and information flow. Most importantly, her studies include a broader range of patients than those permitted in clinical trials, allowing for a potentially more realistic look into the implications and outcomes of using CGRP antagonists. This podcast is sponsored in part by Amgen/Novartis an ..read more

In this episode, we hear a brief, yet informative explanation on how best to determine which migraine patients are candidates for Botox by nurse practitioner, Carolyn deBeauport. Additionally, you will hear what patients can expect when using Botox to manage migraine, including side effects, injection placements, associated costs and more. This podcast is sponsored in part by Amgen/Novartis and Alder BioPharmaceuticals. *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the content is not intended to be a subs ..read more

Bob Bratzler, Ph.D. talks about a potential migraine treatment that was actually discovered by chance. Surprisingly, the use of a particular glaucoma medication was bringing headache relief to some patients who had migraine disease as well. This medication contains prostaglandins... The interesting thing is that prostaglandins are usually associated with causing pain, not preventing it... This medication is now undergoing a clinical trial for use as a migraine preventive treatment. This podcast is sponsored in part by Alder BioPharmaceuticals and Teva Pharmaceutical Industries.  *The contents ..read more

Neurologist Dr. Stewart Tepper explains how the new, "designer" CGRP blocking migraine treatments work, how they are delivered and what to expect for efficacy. Dr. Tepper's presentation was recorded in June 2018, after the first of these medications became available to patients in the U.S.   This podcast is sponsored in part by Alder BioPharmaceuticals and Teva Pharmaceutical Industries.  *The contents of this podcast/video are intended for general informational purposes only and do not constitute medical or legal advice; the content is not intended to be a substitute for professional medical ..read more

In this episode, we share a presentation given by otolaryngologist Dr. Mark Mehle (MAY-LEE). Despite being geared for the continuing education of other physicians, the content should prove to be very useful for patients to discuss with their own doctors regarding their rhinosinusitis symptoms. Dr. Mehle found that 3 out of 4 of the sinus headache patients referred to him were also positive for migraine. He believes anyone treating rhinosinusitis should be well-versed in migraine care, and that they are 2 parts of the same disease. This podcast is sponsored in part by Amgen/Novartis and Alder B ..read more